Delayed cytokine mRNA expression kinetics after t-lymphocyte costimulation: A quantitative measure of the efficacy of cyclosporin A-based immunosuppression

Clinical Chemistry

Volumn 48, Issue 12, 2002, Pages 2225-2231

  Härtel, Christoph ^a   Fricke, Lutz ^a   Schumacher, Nina ^a   Kirchner, Holger ^a   Müller Steinhardt, Michael ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD28 ANTIGEN; CD3 ANTIGEN; CYCLOSPORIN A; CYTOKINE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MONOTHERAPY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0036893274     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.12.2225     Document Type: Article

References (20)

1. Stein CM, Murray JJ, Wood AJ. Inhibition of stimulated interleukin-2 production in whole blood: A practical measure of cyclosporine effect. Clin Chem 1999;45:1477-84.
2. Burke JF Jr, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, Van Buren DH, et al. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994;331:358-63.
3. Bouma GJ, Hollander DA, Meer-Prins EM, van Bree SP, van Rood JJ, van der Woude FJ, et al. In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. Transplantation 1996;62:1422-9.
4. Kerman RH, Kimball PM, Lindholm A, Van Buren CT, Katz SM, Lewis RM, et al. Immune risk factors: Impact on the incidence and diagnosis of rejection. Transplant Proc 1993;25:23-5.
5. Tsünoda SM, Aweeka FT. The use of therapeutic drug monitoring to optimise immunosuppressive therapy. Clin Pharmacokinet 1996;30:107-40.
6. Liu J. FK506 and cyclospoirin, molecular probes for studying intracellular signal transduction. Immunol Today 1993;14:290-5.
7. Paliogianni F, Ahuja SS, Balow JP, Balow JE, Boumpas DT. Novel mechanism for inhibitioh of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J Immunol 1993;151:4081-9.
8. Elion GB. The George Hitchings and Gertrude Elion Lecture. The pharmacology of azothioprine. Ann N Y Acad Sci 1993;685:400-7.
9. Hartel C, Bein G, Kirchner H, Kluter H. A human whole-blood assay for analysis of T-cell function by quantification of cytokine mRNA. Scand J Immunol 1999;49:649-54.
10. Yoshimura N, Kahan BD. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphoytes in kidney transplant recipients. Transplantation 1985;40:661-6.
11. McKenna RM, Rush DN, Bakkestad-Legare P, Jeffery JR. Interleukin 2, interferon, and lymphotoxin in renal transplant recipients. Transplantation 1988;45:76-81.
12. van den Berg AP, Twilhaar WN, van Son WJ, van der Bij W, Klompmaker IJ, Slooff MJ, et al. Quantification of immunosuppression by flow cytometric measurement of intracellular cytokine synthesis. Transplant Int 1998;11(Suppl 1):S318-21.
13. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
14. Kruse N, Moriabadi NF, Toyka KV, Rieckmann P. Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells. J Immunol Methods 2001;247:131-9.
15. Hartel C, Bein G, Muller-Steinhardt M, Kluter H. Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Methods 2001;249:63-71.
16. Zucker C, Zucker K, Asthana D, Carreno M, Viciana AL, Ruiz P, et al. Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection. Hum Immunol 1996;45:1-12.
17. Batiuk TD, Pazderka F, Enns J, DeCastro L, Halloran PF. Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible. J Clin Invest 1995;96:1254-60.
18. Kirchner H, Kleinicke C, Digel W. A whole-blood technique for testing production of human interferon by leukocytes. J Immunol Methods 1982;48:213-9.
19. Geginat J, Clissi B, Moro M, Dellabona P, Bender JR, Pardi R. CD28 and LFA-I contribute to cyclosporin A-resistant T cell growth by stabilizing the IL-2 mRNA through distinct signaling pathways. Eur J Immunol 2000;30:1136-44.
20. June CH, Ledbetter JA, Lindsten T, Thompson CB. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes. J Immunol 1989;143:153-61.